Abstract
Studies using tissue obtained at autopsy suggest that changes in cholinergic neurons could be important in the pathology of schizophrenia.1, 2, 3, 4 We have previously reported a decrease in [3H]pirenzepine binding5 and [3H]AF-DX 384 binding6 to caudate-putamen (CP) from subjects who had schizophrenia. Under the conditions chosen, [3H]pirenzepine would predominately bind to muscarinic1 (M1) and muscarinic4 (M4) receptors,7whereas [3H]AF-DX 384 would mainly bind to muscarinic2 (M2) and M4 receptors.8 Given the relative concentrations of M1, M2 and M4 receptors in the human CP and the magnitude of the decreases in radioligand binding in schizophrenia, our results most likely reflected a change in the density of M1 and M2 receptors in the CP from the schizophrenic subjects. In situ hybridisation has now been used to determine levels of m1 and m2 mRNA in CP from 14 schizophrenic and 16 control subjects previously used for radioligand binding. m2 mRNA in the CP from the schizophrenic and control subjects was below the sensitivity of in situhybridisation. There was no difference in the levels of m1 mRNA in CP from schizophrenic and control subjects (mean ± SEM: 103 ± 16 vs106 ± 17 fmol [35S]oligonucleotide probe g−1estimated tissue equivalents, P = 0.91). In conclusion, data from our radioligand binding studies show decreases in [3H]pirenzepine binding that are likely to reflect a decrease in the density of M1 receptors in CP from schizophrenic subjects. Our data in this study show the absence of a concomitant change in mRNA coding for that receptor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Karson GN, Casanova MF, Kleinman JE, Griffin WT . Choline acetyltransferase in schizophrenia Am J Psychiatry 1993; 150: 454–459
Bracha HS, Kleinman JE . Postmortem neurochemistry in schizophrenia Psychiatr Clin North Am 1986; 9: 133–141
Owen F, Cross AJ, Crow TJ, Lofthouse R, Poulter M . Neurotransmitter receptors in brain in schizophrenia Acta Psychiatr Scand Suppl 1981; 291: 20–28
Watanabe S, Nishikawa T, Takashima M, Toru M . Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics Life Sci 1983; 33: 2187–2196
Dean B, Crook JM, Opeskin K, Keks N, Copolov DL . The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia Mol Psychiatry 1996; 1: 54–58
Crook JM, Dean B, Pavey G, Copolov DL . The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia Life Sci 1999; 64: 1761–1771
Vilaro MT, Wiederhold KH, Palacios JM, Mengod G . Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography Neuroscience 1992; 47: 367–393
Trankle C, Andresen I, Lambrecht G, Mohr K . M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site Mol Pharmacol 1998; 53: 304–312
Vanderheyden P, Ebinger G, Dierckx R, Vauquelin G . Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia J Neurol Sci 1987; 82: 257–269
Ritter LM, Meador-Woodruff JH . Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression Biol Psychiatry 1997; 42: 155–164
Eastwood SL, Hefferman J, Harrison PJ . Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes Mol Psychiatry 1997; 2: 322–329
Bolden-Watson C, Watson MA, Murray KD, Isackson PJ, Richelson E . Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra J Neurochem 1993; 61: 1141–1143
Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC . The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins Neurosci Lett 1995; 200: 151–154
Hill C, Keks NA, Roberts S, Opeskin K, Dean B, Copolov DL . Postmortem brain studies in schizophrenia: the problems of diagnosis Am J Psychiatry 1996; 153: 533–537
American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (Third edition—revised) American Psychiatric Association: Washington DC 1987
Duvernoy H . The human brain: surface three-dimensional sectional anatomy and MRI Springer-Verlag: Wien 1991
Kimmel AR, Berger SL . Preparation of cDNA and the generation of cDNA libraries: overview Meth Enzymol 1987; 152: 307–316
Acknowledgements
B Dean is currently the recipient of a NARSAD Young Investigator Award. JM Crook was the holder of a NH&MRC Dora Lush Scholarship (No. 977415). This work was financed in part by the Rebecca L Cooper Medical Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dean, B., Crook, J., Pavey, G. et al. Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia. Mol Psychiatry 5, 203–207 (2000). https://doi.org/10.1038/sj.mp.4000684
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000684
Keywords
This article is cited by
-
Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system
Translational Psychiatry (2023)
-
Increased Density of Prohibitin-Immunoreactive Oligodendrocytes in the Dorsolateral Prefrontal White Matter of Subjects with Schizophrenia Suggests Extraneuronal Roles for the Protein in the Disease
NeuroMolecular Medicine (2012)
-
A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia
Molecular Psychiatry (2008)
-
Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol
Journal of Neural Transmission (2008)
-
Towards a muscarinic hypothesis of schizophrenia
Molecular Psychiatry (2007)